The most common (72.7%) and well-characterized TP53 mutations among the 80,400 cancer cases reported in the Universal Mutation Database (UMD) are missense mutations in the DNA-binding domain (DBD), signifying that DNA binding is crucial for the tumor suppressive function [16,26]. Here, TP53 is linked to neoplasm.